INTRODUCTION
the first week, but does not continue to rise afterwards (6) . In surgical ICU and in trauma ICU thrombocytopenia usually develops as a result of bleeding and massive hemotransfusions (8) . On the other hand, in medical ICU bleeding usually occurs as a consequence of thrombocytopenia (9) . Critically ill patients with platelet count <50×10 9 /L have a four to fivefold increased risk for bleeding in comparison to patients with platelet count >50×10 9 /L (9). It is known that thrombocytopenia has a negative prognostic value in ICU patients and is an independent risk factor for mortality in these patients (4, 10) . Moreover, significant changes in platelet count (6) , degree of thrombocytopenia (11, 12) and non-resolution of thrombocytopenia (13) also have a negative prognostic value in ICU patients. Severe community acquired pneumonia is a community acquired pneumonia that requires treatment in ICU (14) . Approximately 10% of patients hospitalized with CAP require treatment in ICU and mortality from this condition is 21-58% (15) (16) (17) . Respiratory failure from pneumonia is one of the most common conditions treated in ICU. Thrombocytopenia on admission to ICU is encountered in 25% of patients with severe CAP (11) . In context of critical care thrombocytopenia has mostly been studied in critically ill patients in general. Currently the amount of published data on thrombocytopenia in patients with severe CAP is limited, thus it is important to determine whether thrombocytopenia and changes in platelet count can be used as prognostic marker in this group of patients.
AIM OF THE STUDY
The aim of our study was to determine the incidence and predictive value of thrombocytopenia in patients with severe community-acquired pneumonia.
MATERIAL AND METHODS
We conducted a retrospective cohort study using clinical records from patients admitted to the Pauls Stradins Clinical University Hospital Intensive Care and Reanimation Unit between January 1, 2011 and December 31, 2014. Patient records were obtained from Pauls Stradins Clinical University Hospital Archive. Adult patients (>18 years) with diagnosis of severe CAP were included in this study. We excluded patients who had any of the following criteria: acquired or congenital thrombocytopathy, recent chemotherapy, non-fractioned heparin therapy, alcohol abuse, hepatic cirrhosis, immunocompromised state (HIV infection and organ transplant recipients) and less than 2 daily blood tests. We registered and analyzed the following data obtained from the clinical records: age, gender, length of stay (LOS) in ICU, hospital outcome, ICU outcome, full diagnosis, causative microbial organism, SOFA score on admission to ICU, CURB-65 score on admission to the hospital, leukocyte count on admission to ICU, C-reactive protein value on admission to ICU, daily platelet count (up to 20 days of ICU stay or death, whichever happened earlier). In results related to mortality, ICU mortality was analyzed unless stated otherwise. Thrombocytopenia was defined as platelet count (18) . Severe community acquired pneumonia was defined as a community acquired pneumonia that required treatment in ICU (14) . Statistical analysis was performed using software SPSS 22.0. Data were tested for normality using KolmogorovSmirnov test. Normally distributed data were compared using Independent Samples T-Test and displayed as mean ± standard deviation (SD). Data with skewed distribution were compared using Mann-Whitney U test and displayed as median and interquartile range [IQR] . For comparison of categorical data Chi-Square test was used and data were displayed as percentages and absolute values. Multiple logistic regression analysis was used to determine whether non-resolution of thrombocytopenia is associated with higher mortality and odds ratio (OR) and 95% confidence interval (CI) was calculated. Spearman correlation (r s ) analysis was performed to find correlations. Receiver-operator (ROC) curves and analysis of area under the curve (AUC) were used to determine discriminative power. P value <0.05 was considered statistically significant.
RESULTS
Between January 1, 2011 and December 31, 2014, 313 patients were admitted to ICU with diagnosis of pneumonia, of whom we excluded 105 patients because either a clinical record could not be found (7 patients), or it was not a community acquired pneumonia (98 patients). Out of remaining 208 patients with severe CAP, we excluded 110 patients due to preexisting exclusion criteria: less than two daily blood tests available (18 patients), alcohol abuse (40 patients), hepatic cirrhosis (8 patients), non-fractioned heparin therapy (22 patients), HIV infection (7 patients), recent chemotherapy (8 patients), patients who had organ transplantation (5 patients), splenectomy (1 patient) and splenomegaly (1 patient). A total of 98 patients were included in the study, 58 (59%) men and 40 (41%) women. The mean age was 61±17.9 years. ICU mortality was 46% (n=45), while hospital mortality was 54% (n=53). Median [IQR] LOS in ICU was 7 [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] days. Thrombocytopenia was encountered in 57 (58%) patients during their stay in ICU, of them in 33 (58%) patients it was present on admission to ICU, while in 24 patients (42%) it developed during their stay in ICU. Moreover, presence of thrombocytopenia and degrees of thrombocytopenia also did not differ significantly between the two groups ( Table 1) . /L, p=0.008) ( Table 3) . Out of 57 patients who had thrombocytopenia, in 40 patients (70%) thrombocytopenia did not resolve during ICU stay. Patients with non-resolution of thrombocytopenia had higher mortality in comparison to patients in whom thrombocytopenia resolved (26 (65%) vs 4 (24%), p=0.008). Non-resolution of thrombocytopenia was associated with higher mortality (OR 5.5, 95% CI 1.6-18.7, p=0.006). After adjusting for age, gender and SOFA score we found non-resolution of thrombocytopenia to be an independent risk factor for mortality (OR 8, 95% CI 1.7-37, p=0.008) ( Table 4) .
DISCUSSION
Since the amount of published data on thrombocytopenia in patients with severe CAP is limited we also compared our results to studies where thrombocytopenia was investigated in patients with sepsis and critically in patients.
Our findings were similar to the study carried out by Brogly and colleagues, in which thrombocytopenia was studied in patients with severe CAP: they also did not find difference in ICU mortality between patients with thrombocytopenia and without thrombocytopenia, and they had similar incidence of thrombocytopenia on admission to ICU (11) . In respect to non-resolution of thrombocytopenia as a predictor of a negative outcome our findings were similar to study carried out by Vencata and colleagues on patients with severe sepsis and septic shock. In their study non-resolution of thrombocytopenia was associated with higher mortality and they also did not find the difference in mortality (28 day mortality) between patients with thrombocytopenia and patients without thrombocytopenia (13) .
Concerning results related to platelet count kinetics our results were similar to studies carried out by Akca and colleagues (6) and Moreau and colleagues (19) , who studied platelet count in critically ill patients, and to previously mentioned study by Vencata and colleagues (13) . Both in our study and the study by Vencata and colleagues duration of thrombocytopenia was four days. In the studies by Akca and colleagues and Moreau and colleagues the lowest platelet count in both survivors and in non-survivors was on fourth day of ICU stay, in our study non-survivors had the lowest platelet on fourth day of ICU stay, while survivors on fifth. We found correlation between platelet count and leukocyte count, but did not find correlation between platelet count and CRP, which might be attributed to the fact that during a severe inflammation hemophagocytosis of hematopoietic cells takes place (20, 21) and also due to changes in blood volume. However, we did not find a correlation between platelet count and erythrocyte count. Erythrocyte count should have also been affected by changes in blood volume and hemophagocytosis, because erythrocytes, leukocytes and platelets are produced from the same precursor cell. Possibly this absence of correlation between platelets and erythrocytes could be explained by the fact that erythrocytes have longer lifespan in comparison to platelets and leukocytes and thus change in their count is not as rapid. Since both leukocytes and platelets (22, 23] are actively involved in inflammation, correlation between them could be explained by a consumption in inflammatory processes. There are certain limitations in our study. Firstly, we used SOFA score to determine severity of illness. Platelet count is one of the parameters assessed by SOFA score, thus it would have been more correctly to use other scoring system which does not comprise platelet count, such as APACHE II scoring system. Also, as we studied thrombocytopenia in patients with pneumonia, we could not exclude patients who received antibiotics. It is well known that certain antibiotics, such as penicillin may cause thrombocytopenia (24) . Since we carried out a retrospective study we could not analyze correlation between platelet count and procalcitonin levels, because it was determined in a limited number of patients. In patients with CAP, level of procalcitonin is related to severity of illness and is an effective mortality predictor (25) . In similar studies (13) patients who received non-fractioned heparin therapy were not excluded, because if heparin-induced thrombocytopenia (HIT) was suspected, anti-platelet factor 4/heparin antibodies were assessed. Since our study is retrospective, and in Latvia these antibodies are not routinely assessed in suspicion of HIT, we had to exclude patients who received non-fractioned heparin therapy, because we could not acknowledge the numbers of patients with HIT and how it could have affected our results.
CONCLUSIONS
Thrombocytopenia is frequently encountered in patients with severe community-acquired pneumonia. Thrombocytopenia at any point of ICU stay is associated with higher hospital mortality. Resolution of thrombocytopenia is associated with better clinical outcome.
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